Trial Details

TERMINATED
Basic Information
Clinical ID c1490
Identifier NCT01659138
Trial Title Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: SAR339658|OTHER: Placebo
Participant Information
Sponsor Sanofi
City Sun City
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2025-08-12
Primary Completion Date 2025-06-14
Completion Date 2025-04-16